6533b851fe1ef96bd12a992a
RESEARCH PRODUCT
Running away from cardiovascular disease at the right speed: The impact of aerobic physical activity and cardiorespiratory fitness on cardiovascular disease risk and associated subclinical phenotypes
Anurag MehtaBarry A. FranklinAmbarish PandeyJari A. LaukkanenCarl J. LavieNitin KondamudiRoss ArenaUlrik Wisløffsubject
medicine.medical_specialtyphysical activityheart failureDisease030204 cardiovascular system & hematologyLower risksydämen vajaatoimintaCoronary artery disease03 medical and health sciences0302 clinical medicinepreventionInternal medicinemedicineAerobic exerciseatrial fibrillation030212 general & internal medicineSubclinical infectionkuntoliikuntabusiness.industryAtrial fibrillationCardiorespiratory fitnessaerobinen harjoittelueteisvärinämedicine.diseasefitnessfyysinen kuntoHeart failuresydän- ja verisuonitauditCardiologyCardiology and Cardiovascular Medicinebusinesscoronary artery diseasefyysinen aktiivisuusdescription
Higher levels of physical activity (PA) and cardiorespiratory fitness (CRF) are associated with lower risk of incident cardiovascular disease (CVD). However, the relationship of aerobic PA and CRF with risk of atherosclerotic CVD outcomes and heart failure (HF) seem to be distinct. Furthermore, recent studies have raised concerns of potential toxicity associated with extreme levels of aerobic exercise, with higher levels of coronary artery calcium and incident atrial fibrillation noted among individuals with very high PA levels. In contrast, the relationship between PA levels and measures of left ventricular structure and function and risk of HF is more linear. Thus, personalizing exercise levels to optimal doses may be key to achieving beneficial outcomes and preventing adverse CVD events among high risk individuals. In this report, we provide a comprehensive review of the literature on the associations of aerobic PA and CRF levels with risk of adverse CVD outcomes and the preceding subclinical cardiac phenotypes to better characterize the optimal exercise dose needed to favorably modify CVD risk. peerReviewed
year | journal | country | edition | language |
---|---|---|---|---|
2020-11-01 | Progress in Cardiovascular Diseases |